Ken Griffin Aura Biosciences, Inc. Call Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$6.81 - $7.89 $2,724 - $3,156	400 Added 100.0%	800 $6,000
Q1 2024 May 15, 2024	BUY	$7.09 - $9.24 $1,418 - $1,848	200 Added 100.0%	400 $3,000
Q4 2023 Feb 14, 2024	BUY	$7.02 - $11.98 $1,404 - $2,396	200 New	200 $1,000
Q2 2023 Aug 14, 2023	BUY	$8.51 - $13.33 $8,510 - $13,330	1,000 New	1,000 $12,000

40.4M

800

1.8K

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $256M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.